Loading…
Based on limited metadata, R & B Medical Group Inc. received an FDA Warning Letter on January 15, 2020, regarding biologics products. Without access to the full letter text or specific subject line details, the exact nature of the violations cannot be determined from the available information. The warning falls under FDA's biologics regulatory authority, which typically addresses concerns related to manufacturing, quality control, or compliance with biologics licensing requirements. Additional documentation would be needed to identify the specific regulatory violations cited.